Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.00
Bid: 91.00
Ask: 93.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.198%)
Open: 92.00
High: 92.00
Low: 92.00
Prev. Close: 92.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Aug 2021 07:00

RNS Number : 8021I
Gattaca PLC
17 August 2021
 

17 August 2021

 

Gattaca plc

("Gattaca", "the Group" or "the Company")

 

Trading Update for 12 months ended 31 July 2021

Performance ahead of expectations

 

 

Gattaca plc (LSE-AIM: GATC), the UK's leading specialist Engineering and Technology staffing business, today provides the following trading update for the 12 months ended 31 July 2021.

 

Following our trading update announcement on 21 May 2021, we expect continuing underlying PBT1 and adjusted net cash (excluding IFRS16 lease liabilities) to be above market expectations for FY 2021.

 

H2 2021 continuing Net Fee Income ("NFI") was 7% higher than H1 2021, with the full year NFI at £42.5m (FY 2020: £52.8m), reflecting the market impact of the COVID-19 pandemic over the entire reporting period.

 

We continue to add sales and delivery resource across the business, increasing front line headcount by 13% since January whilst tightly managing the overall cost base.

 

Consequently, subject to final adjustments and audit, we expect our continuing underlying PBT for the full year to be in excess of £3m (market consensus £2.7m).

 

Adjusted Net Cash (excluding IFRS16 lease liabilities) is expected to be £20m2 (31 July 2020: £27m) largely driven by repayment of deferred VAT (£4.7m)

 

All of our businesses successfully transferred to our global technology platform in Q4 enabling the business to have a consistent view of activity and performance across all of our operating units. 

We have seen increased activity from our "RPO" (Permanent Recruitment Process Outsourcing solutions) clients as the market recovery has been led by permanent recruitment both in contingent and solutions products. There is further improvement to come on the contract front including in our core infrastructure unit, which will benefit from strong demand driven by major initiatives such as UK Fibre investment, HS2 and Offshore 2025, which we are seeing already positively impacting hiring. Our defence business continues to perform strongly. We also anticipate continuing high demand for technology skills as the pace of digitisation continues to accelerate.

 

We have determined that our sales operations in Mexico and South Africa are sub-scale and we exited both at the end of July and these businesses will be treated as discontinued in our FY 2021 results.

 

In light of the improved performance and assuming a continuation of the current positive trends, the Board anticipates the recommendation of a modest dividend when the full year results are announced.

 

The Group expects to announce its full year results for the 12 months to 31 July 2021 on Thursday 4 November 2021.

 

 

 

Kevin Freeguard, Chief Executive Officer said:

 

"Following our upgrade in May, I am pleased that our profit results will again be ahead of expectations. Whilst the pandemic continues to impact activity across our markets, it is clear that we have now entered the next phase of recovery. Our new global technology platform will increase our ability to collaborate and drive performance across the business. At the same time, our continued investment in sales and delivery resources will enable us to capitalise on the continuing opportunities as our markets, including Infrastructure and Defence, emerge from the pandemic."

 

1 Continuing underlying results exclude the NFI and (losses) / profits before taxation of discontinued operations. The combined NFI of Mexico and South Africa in the year was £1.0m and losses before tax were £(0.2)m (2020: NFI £1.5m and profit before tax £0.2m

2 VAT deferrals at 31 July 2021 were £5.6m (31 July 2020: £10.3m)

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

Salar Farzad, Chief Financial Officer

 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Robert Morton

Euan Brown

 

 

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Jos Bieneman

Elizabeth Kittle

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEQLFFFVLFBBX
Date   Source Headline
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:01 amRNSBlock Listing Six Monthly Return
3rd Apr 20237:00 amRNSLaunch of Share Buy-back
30th Mar 20237:00 amRNSInterim results
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.